In the realm of cancer research, in vitro cancer cell-based assay serves as a cost-effective strategy to predict mode of action, immunoreactivity, and efficacy well before venturing into in vivo models. Creative Bioarray is a company that specializes in providing a wide range of services and products for life science research, drug discovery, and biotechnology applications. One of our areas of expertise is in vitro cancer cell-based assays and high-throughput drug screening.
High-throughput drug screening is a process used by pharmaceutical and biotechnology companies to rapidly test large numbers of potential drug compounds for their effectiveness in treating diseases. In the context of cancer research, high-throughput drug screening involves exposing cancer cells to a vast library of compounds to identify potential drug candidates that exhibit desirable effects, such as inhibiting cancer cell growth or inducing cancer cell death. This approach allows researchers to quickly identify promising drug candidates for further investigation. Creative Bioarray offers services to facilitate this process. A variety of in vitro cancer cell-based assays, which can be used to investigate processes such as cell proliferation, apoptosis (programmed cell death), migration, invasion, and drug response.